|
End-of-day quote
Shenzhen S.E.
2026-10-21
|
5-day change | 1st Jan Change | ||
| 3.800 CNY | -0.52% |
|
-3.55% | -14.22% |
| 08-26 | Fuan Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 05-22 | Fuan Pharmaceutical Subsidiary Gets China Approval for Three Injectable Drugs | MT |
| Market Cap | 4.52B 677M 603M 559M 506M 952M 63.89B 964M 6.7B 2.63B 33.59B 2.54B 2.49B 107B | P/E 2024 |
18.6x | P/E 2025 | 73.8x |
|---|---|---|---|---|---|
| Enterprise Value | 4.28B 642M 572M 529M 479M 903M 60.56B 913M 6.35B 2.49B 31.83B 2.41B 2.36B 101B | EV / Sales 2024 |
2.15x | EV / Sales 2025 | 2.9x |
| Free-Float |
68.44% | Yield 2024 |
1.12% | Yield 2025 | 1.58% |
| 1 day | -0.52% | ||
| 1 week | -3.55% | ||
| Current month | -2.31% | ||
| 1 month | -4.76% | ||
| 3 months | +3.54% | ||
| 6 months | -8.21% | ||
| Current year | -14.22% |
| 1 week | 3.78 |  | 4.02 |
| 1 month | 3.78 | | 4.1 |
| Current year | 3.24 | | 4.75 |
| 1 year | 3.24 | | 5 |
| 3 years | 2.92 | | 5.68 |
| 5 years | 2.92 | | 5.68 |
| 10 years | 2.87 | | 11.51 |
| Manager | Title | Age | Since |
|---|---|---|---|
Lu Wang
CEO | Chief Executive Officer | 42 | 2023-12-03 |
Xue Song Yu
DFI | Director of Finance/CFO | 57 | 2009-09-18 |
Qin Tang
SEC | Corporate Secretary | 57 | 2009-09-18 |
| Director | Title | Age | Since |
|---|---|---|---|
Tian Xiang Wang
CHM | Chairman | 70 | 2009-09-18 |
Qin Tang
BRD | Director/Board Member | 57 | 2009-09-18 |
Xue Song Yu
BRD | Director/Board Member | 57 | 2018-12-20 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 1/7/20 | Sell | Director | 3,000,000 | 0.3361% | ||
| 1/2/20 | Sell | Executive/Senior Manager | 30,300 | 0.0034% | ||
| 1/2/20 | Sell | Chief Financial Officer | 42,200 | 0.0047% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.52% | -3.55% | -14.22% | -9.09% | 677M | |
| -1.01% | +5.13% | +58.93% | +117.36% | 1,133B | |
| -0.61% | +1.52% | +34.34% | +68.48% | 621B | |
| -1.48% | +0.47% | +23.08% | +94.76% | 503B | |
| +0.54% | +5.69% | +39.60% | +64.02% | 379B | |
| +1.07% | +1.70% | +71.06% | +45.98% | 370B | |
| +0.30% | +3.44% | +21.35% | +49.62% | 292B | |
| -0.03% | +2.55% | +1.12% | +20.94% | 262B | |
| -0.14% | +2.87% | +45.56% | +57.22% | 237B | |
| -1.88% | +0.02% | +23.77% | +97.39% | 190B | |
| Average | -0.08% | +3.12% | +30.46% | +60.67% | 398.87B | |
| Weighted average by Cap. | +0.33% | +4.18% | +40.83% | +79.36% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.39B 358M 319M 295M 267M 504M 33.8B 510M 3.54B 1.39B 17.77B 1.34B 1.32B 56.61B | 1.74B 260M 232M 215M 194M 366M 24.57B 371M 2.58B 1.01B 12.91B 977M 956M 41.15B |
| Net income | 280M 41.91M 37.35M 34.58M 31.29M 58.95M 3.95B 59.65M 415M 163M 2.08B 157M 154M 6.62B | 77M 11.53M 10.28M 9.51M 8.61M 16.22M 1.09B 16.41M 114M 44.76M 572M 43.26M 42.36M 1.82B |
| Net Debt | -171M -25.54M -22.76M -21.07M -19.07M -35.93M -2.41B -36.35M -253M -99.14M -1.27B -95.81M -93.82M -4.04B | -236M -35.38M -31.53M -29.19M -26.42M -49.77M -3.34B -50.36M -350M -137M -1.76B -133M -130M -5.59B |
Employees
2,988
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-21 | CN¥3.800 | -0.52% | 13,201,000 |
| 26-10-20 | CN¥3.820 | -0.26% | 12,242,500 |
| 26-10-19 | CN¥3.830 | -2.05% | 20,937,600 |
| 26-10-16 | CN¥3.910 | -0.26% | 26,192,700 |
| 26-10-15 | CN¥3.920 | -0.51% | 17,169,008 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 300194 Stock
Select your edition
All financial news and data tailored to specific country editions
